Hepion Pharmaceuticals, Inc. (HEPA)
Develops experimental drugs to treat liver diseases and cancer.
$0.05-0.04%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+7.0%
The outlook
HEPA is trading near the bottom of its 52-week range and well below both its 50- and 200-day moving averages, signaling a sustained downtrend. Analyst coverage appears thin or unavailable. The overall sentiment leans decidedly bearish.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range17% of the way from its 52-week low to high
Market cap
$1.3M
52-wk high
$0.11
52-wk low
$0.03
50-day avg
$0.07
200-day avg
$0.06
Trailing P/E
0.0